C

Cel-Sci Corp
D

CVM

8.70000
USD
0.63
(7.81%)
مغلق
حجم التداول
2,843
الربح لكل سهم
-9
العائد الربحي
-
P/E
-1
حجم السوق
44,674,683
أصول ذات صلة
A
ACAD
0.820
(3.35%)
25.330 USD
B
BCRX
-0.09000
(-1.06%)
8.36500 USD
C
CLDX
0.555
(2.22%)
25.500 USD
T
TNXP
-8.130
(-13.66%)
51.370 USD
المزيد
الأخبار المقالات

العنوان: Cel/Sci Corp

القطاع: Healthcare
الصناعة: Biotechnology
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.